Unknown

Dataset Information

0

EIAV-based retinal gene therapy in the shaker1 mouse model for usher syndrome type 1B: development of UshStat.

ABSTRACT: Usher syndrome type 1B is a combined deaf-blindness condition caused by mutations in the MYO7A gene. Loss of functional myosin VIIa in the retinal pigment epithelia (RPE) and/or photoreceptors leads to blindness. We evaluated the impact of subretinally delivered UshStat, a recombinant EIAV-based lentiviral vector expressing human MYO7A, on photoreceptor function in the shaker1 mouse model for Usher type 1B that lacks a functional Myo7A gene. Subretinal injections of EIAV-CMV-GFP, EIAV-RK-GFP (photoreceptor specific), EIAV-CMV-MYO7A (UshStat) or EIAV-CMV-Null (control) vectors were performed in shaker1 mice. GFP and myosin VIIa expression was evaluated histologically. Photoreceptor function in EIAV-CMV-MYO7A treated eyes was determined by evaluating ?-transducin translocation in photoreceptors in response to low light intensity levels, and protection from light induced photoreceptor degeneration was measured. The safety and tolerability of subretinally delivered UshStat was evaluated in macaques. Expression of GFP and myosin VIIa was confirmed in the RPE and photoreceptors in shaker1 mice following subretinal delivery of the EIAV-CMV-GFP/MYO7A vectors. The EIAV-CMV-MYO7A vector protected the shaker1 mouse photoreceptors from acute and chronic intensity light damage, indicated by a significant reduction in photoreceptor cell loss, and restoration of the ?-transducin translocation threshold in the photoreceptors. Safety studies in the macaques demonstrated that subretinal delivery of UshStat is safe and well-tolerated. Subretinal delivery of EIAV-CMV-MYO7A (UshStat) rescues photoreceptor phenotypes in the shaker1 mouse. In addition, subretinally delivered UshStat is safe and well-tolerated in macaque safety studies These data support the clinical development of UshStat to treat Usher type 1B syndrome.

SUBMITTER: Zallocchi M 

PROVIDER: S-EPMC3976400 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Usher syndrome type 1B is a combined deaf-blindness condition caused by mutations in the MYO7A gene. Loss of functional myosin VIIa in the retinal pigment epithelia (RPE) and/or photoreceptors leads to blindness. We evaluated the impact of subretinally delivered UshStat, a recombinant EIAV-based lentiviral vector expressing human MYO7A, on photoreceptor function in the shaker1 mouse model for Usher type 1B that lacks a functional Myo7A gene. Subretinal injections of EIAV-CMV-GFP, EIAV-RK-GFP (ph  ...[more]

Similar Datasets

Unknown Lentiviral gene replacement therapy of retinas in a mouse model for Usher syndrome type 1B.
| S-EPMC9307148 | biostudies-literature
Unknown Retinal disease course in Usher syndrome 1B due to MYO7A mutations.
| S-EPMC3263772 | biostudies-literature
Unknown Local gene therapy durably restores vestibular function in a mouse model of Usher syndrome type 1G.
| S-EPMC5594693 | biostudies-literature
Unknown Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c.
| S-EPMC5340578 | biostudies-literature
Unknown The Time Course of Deafness and Retinal Degeneration in a Kunming Mouse Model for Usher Syndrome.
| S-EPMC4871471 | biostudies-literature
Unknown Severe retinal degeneration at an early age in Usher syndrome type 1B associated with homozygous splice site mutations in MYO7A gene.
| S-EPMC6010603 | biostudies-literature
Unknown Efficacy, pharmacokinetics, and safety in the mouse and primate retina of dual AAV vectors for Usher syndrome type 1B.
| S-EPMC9996380 | biostudies-literature
Unknown Gene Therapy Restores Balance and Auditory Functions in a Mouse Model of Usher Syndrome.
| S-EPMC5363211 | biostudies-literature
Unknown Retinal Gene Therapy for Usher Syndrome: Current Developments, Challenges, and Perspectives.
| S-EPMC8478317 | biostudies-literature
Unknown Identification of a rat model for usher syndrome type 1B by N-ethyl-N-nitrosourea mutagenesis-driven forward genetics.
| S-EPMC1449770 | biostudies-literature